JP Morgan Raises Regeneron Pharma Price Target to $950.00
JP Morgan has raised its price target for Regeneron Pharmaceuticals to $950.00 per share from its previous target of $900.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.